Attached files

file filename
EX-99.1 - JOINT PRESS RELEASE ISSUED BY MCKESSON AND PSS WORLD MEDICAL - PSS WORLD MEDICAL INCd453099dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 10, 2012

 

 

PSS WORLD MEDICAL, INC.

(Exact name of Registrant as specified in its charter)

 

 

Commission File Number: 0-23832

 

Florida   59-2280364

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification Number)

4345 Southpoint Blvd.

Jacksonville, Florida

  32216
(Address of principal executive offices)   (Zip code)

Registrant’s telephone number,

including area code

  (904) 332-3000

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01 Other Events.

On December 10, 2012, McKesson Corporation (“McKesson”) and PSS World Medical, Inc. (“PSS World Medical”) issued a joint press release announcing that McKesson has voluntarily withdrawn and re-filed its notification and report form filed under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with the proposed acquisition by McKesson of PSS World Medical. A copy of the joint press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit
No.

  

Description

99.1    Joint press release issued by McKesson and PSS World Medical dated December 10, 2012.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 13, 2012

 

PSS WORLD MEDICAL, INC.
By:  

/s/ David M. Bronson

  Name:   David M. Bronson
  Title:   Executive Vice President and Chief Financial Officer


EXHIBIT INDEX

 

Exhibit
No.

  

Description

99.1    Joint press release issued by McKesson and PSS World Medical dated December 10, 2012.